AEON Biopharma (AEON) Institutional Ownership $0.15 -0.02 (-9.89%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for AEON Biopharma (NASDAQ:AEON)CurrentInstitutional OwnershipPercentage22.78%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$6.52MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$10.80M Get AEON Insider Trade Alerts Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AEON Institutional Buying and Selling by Quarter AEON Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024Geode Capital Management LLC243,168$255K0.0%+30.1%0.622% 11/15/2024Polar Asset Management Partners Inc.3,599,918$3.78M0.1%-2.0%9.202% 11/15/2024HighTower Advisors LLC23,776$25K0.0%N/A0.061% 11/7/2024Caprock Group LLC62,686$66K0.0%N/A0.160% 8/14/2024Davidson Kempner Capital Management LP90,053$95K0.0%-75.4%0.230% 5/17/2024Shaolin Capital Management LLC21,380$248K0.0%-97.7%0.057% 5/10/2024Vanguard Group Inc.758,992$8.80M0.0%+261.8%2.008% 2/7/2024Formidable Asset Management LLC58,193$419K0.1%-9.5%0.157% 11/9/2023Formidable Asset Management LLC64,311$360K0.1%N/A0.723% 11/6/2023Atalaya Capital Management LP3,675,000$19.83M21.7%N/A41.283% (Data available from 1/1/2016 forward) AEON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AEON shares? During the previous two years, 9 institutional investors and hedge funds held shares of AEON Biopharma. The most heavily invested institutionals were Atalaya Capital Management LP ($19.83M), Vanguard Group Inc. ($8.80M), Polar Asset Management Partners Inc. ($3.78M), Formidable Asset Management LLC ($419K), Geode Capital Management LLC ($255K), Shaolin Capital Management LLC ($248K), and Davidson Kempner Capital Management LP ($95K).Learn more on AEON's institutional investors. What percentage of AEON Biopharma stock is owned by institutional investors? 22.78% of AEON Biopharma stock is owned by institutional investors. Learn more on AEON's institutional investor holdings. Which institutional investors have been buying AEON Biopharma stock? The following institutional investors have purchased AEON Biopharma stock in the last 24 months: Atalaya Capital Management LP ($3.68M), Vanguard Group Inc. ($549.21K), Formidable Asset Management LLC ($64.31K), Caprock Group LLC ($62.69K), Geode Capital Management LLC ($56.31K), and HighTower Advisors LLC ($23.78K). How much institutional buying is happening at AEON Biopharma? Institutional investors have bought a total of 4,431,290 shares in the last 24 months. This purchase volume represents approximately $27.46M in transactions. Which AEON Biopharma major shareholders have been selling company stock? The following institutional investors have sold AEON Biopharma stock in the last 24 months: Shaolin Capital Management LLC ($895.74K), Davidson Kempner Capital Management LP ($276.62K), Polar Asset Management Partners Inc. ($75.08K), and Formidable Asset Management LLC ($6.12K). How much institutional selling is happening at AEON Biopharma? Institutional investors have sold a total of 1,253,558 shares in the last 24 months. This volume of shares sold represents approximately $10.80M in transactions. Related Companies NXTC Major Shareholders CARA Major Shareholders TENX Major Shareholders XCUR Major Shareholders ATHA Major Shareholders GOVX Major Shareholders MIRA Major Shareholders APRE Major Shareholders CYTH Major Shareholders BFRG Major Shareholders This page (NASDAQ:AEON) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AEON Stock Alerts